10 September 2010
Keywords: euro, hypolipidemics, market, set, boom, european, been
Article | 5 May 1998
The European market for hypolipidemics has been growing rapidly,reaching a value of $2.12 billion in 1997, and is expected to expand to $8.12 billion by 2004, according to a new report from Frost & Sullivan.
Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.
FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!
Sign up in less than 60 seconds...no payment needed
Take a no obligations 30 day trial.
Only one trial per user. Find out more details
Subscriptions are £60 per month, pay as you go.
Find out more details.